• March 8, 2024

    Development of the Dai-ichi Life Group Diversity, Equity & Inclusion Statement
    -Creating further value by leveraging the individuality of each employee-

  • March 7, 2024

    Impact Investment in Rakuten Medical, Inc.
    -Supporting the development of a novel cancer treatment called Alluminox Treatment (Photoimmunotherapy) to advance treatment options for cancer patients- PDF

  • February 14, 2024

    Investment in “1st Japan Climate Transition Bond”
    - Encouraging Green Transformation (GX) in Japan - PDF

  • January 31, 2024

    Launching of “DL Sustainability Finance Frameworks” to Provide Financial Support for Corporate Sustainability Initiatives
    - Replacing 100% of bilateral corporate loan flows with sustainable ones in the medium term - PDF

  • December 26, 2023

    Dai-ichi Life Holdings to Establish Joint Research Course at Shimane University Faculty of Medicine
    Our Challenge in Healthcare Innovation by Mental Health x Digital

  • December 21, 2023

    Dai-ichi Life Holdings registered as an adopter of TNFD

  • December 20, 2023

    Dai-ichi Life Holdings Selected for Inclusion
    in the Dow Jones Sustainability Asia Pacific Index

  • November 30, 2023

    Impact Investment in PLANTX Inc.
    -Contributing to environmental conservation through sustainable plant production- PDF

  • September 29, 2023

    Disclosure of "Net Zero Transition Plan"

  • July 14, 2023

    Investment in IFM Net Zero Infrastructure Fund
    - Accelerating the transition to net zero through investments such as renewable energy generation and carbon capture projects. - PDF

  • April 19, 2023

    Impact Investment in KAKEHASHI Inc.
    - Contributing to Medical DX and to Establishing a Sustainable Medical System - PDF